Keyphrases
Ductal Carcinoma in Situ
100%
Microenvironment
100%
Tumor
33%
Breast Cancer Patients
33%
Radiation Therapy
33%
Early Detection
33%
Therapeutic Strategies
33%
Breast Tumor
33%
Tumor Initiation
33%
Tumor Progression
33%
Carcinoma
33%
Immune Cells
33%
Cell-to-cell
33%
Carcinoma Cells
33%
Targeted Treatment
33%
Therapeutic Intervention
33%
Diagnostic Strategy
33%
Receptor Targets
33%
Current Therapeutics
33%
Survival Rate
33%
Metastasizing
33%
Knowledge Level
33%
Tumor Cell Invasion
33%
Fibroblast Cells
33%
Surgical Therapy
33%
Invasive Carcinoma
33%
Unmet Needs
33%
Hormone Receptor
33%
Stromal Tissue
33%
Current Diagnostics
33%
Immune Escape
33%
Enhancing Tumor
33%
Invasive Lesions
33%
Myoepithelial Cells
33%
Strategy Focus
33%
Biochemistry, Genetics and Molecular Biology
Immunocompetent Cell
100%
Tumor Initiation
100%
Cell Invasion
100%
Survival Rate
100%
Myoepithelial Cell
100%
Tumor Progression
100%
Hormone Receptor
100%
Fibroblast
100%
Immunology and Microbiology
Immune Escape
100%
Carcinoma Cell
100%
Immunocompetent Cell
100%
Tumor Cell
100%
Cell Invasion
100%
Survival Rate
100%
Fibroblast
100%
Medicine and Dentistry
Intraductal Carcinoma
100%
Breast Cancer
66%
Biological Marker
33%
Neoplasm
33%
Tumor Progression
33%
Tumor Initiation
33%
Targeted Therapy
33%
Tumor Cell
33%
Carcinoma
33%
Carcinoma Cell
33%
Immunocompetent Cell
33%
Survival Rate
33%
Cell Invasion
33%
Invasive Carcinoma
33%
Hormone Receptor
33%
Fibroblast
33%
Radiation Therapy
33%
Pharmacology, Toxicology and Pharmaceutical Science
Intraductal Carcinoma
100%
Neoplasm
100%
Breast Cancer
66%
Carcinoma
66%
Biological Marker
33%
Survival Rate
33%
Invasive Carcinoma
33%
Hormone Receptor
33%